The Competition Commission of Pakistan (CCP) imposed substantial fines on all GCC-approved medical centers and administrative offices for collusion. The centers were found to have fixed uniform fees, divided the market, and were exploiting customers “by restricting their choice and imposing unfair terms and conditions.” The activities served to guarantee revenues for the medical centers and also eliminated incentives to innovate and improve efficiency.
Featured News
SEC Enforcement Chief Margaret Ryan Steps Down After Six Months
Mar 16, 2026 by
CPI
India’s CCI Prepares Action on Potential Anti-Competitive Conduct in AI Sector
Mar 16, 2026 by
CPI
Proposal Calls for Treating Digital Platform Design Standards Like Physical Infrastructure
Mar 16, 2026 by
CPI
Europe’s Cybersecurity Clock Is Ticking. Here’s What Companies Need to Know
Mar 16, 2026 by
CPI
European Publishers and Startups Call for Swift EU Decision in Google Case
Mar 16, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece